skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

38 Total results for product and free and sample content found

Trialtrove

Novel Biologics for Asthma: Steps on the Long Road to Therapies for Uncontrolled Asthma

By Laura Runkel 17 Jan 2017

After many years of research, the first two novel biologics have been filed for approval for uncontrolled, eosinophilic asthma treatment. Will the hope for truly targeted therapies for uncontrolled asthma now be realized? After many years of research, the first two novel biologics have been filed for approval for uncontrolled, eosinophilic asthma treatment. Will the hope for truly targeted therapies for uncontrolled asthma now be realized?

Trialtrove

Kinase inhibitors in rheumatoid arthritis: where have they been and where are they going?

By ​Gunilla Sturrock 07 Dec 2016

This analysis provides a five year review of the RA kinase inhibitor programs – where have they been and where are they going.

Topics Clinical trial optimization

Trialtrove

2016 Clinical trials roundup: Steady Course or changing tides?

By Doro Shin 07 Dec 2016

Welcome to this year’s roundup where we’ll review clinical trials that initiated in 2015 to elucidate any ongoing, or new, trends within the world of pharma R&D.

Topics Clinical trials

Trialtrove

Collaborations in HIV treatment trials: A help or hindrance for patient recruitment?

By Doro Shin 07 Dec 2016

This analysis takes a closer look at Phase II-III studies in HIV positive patients in order to determine what effect collaboration has on enrollment trends in clinical trials evaluating antiretroviral treatment, if any.

Topics Clinical trial optimization

Trialtrove

Reporting Bias in Clinical Trials: What’s the current status?

By Doro Shin 07 Dec 2016

Citeline is pleased to report that by using Trialtrove to analyze a wide variety of sources, clinical trial transparency is in a much healthier state than shown in previous studies.

Topics Clinical trials

Trialtrove

The Effect of Geographic Breadth on Enrollment

By Doro Shin 07 Dec 2016

Projecting timelines and identifying sites are key elements to consider while planning clinical trials.

Topics Clinical trials

Trialtrove

Innovation In Heart Failure Drug Development - Is There Enough?

By Jake Mathon 02 Dec 2016

Heart failure is a chronic condition that is of major concern to the healthcare community. 5.8 million Americans and 23 million people globally are estimated to have heart failure.

Topics Clinical trial optimization

Trialtrove

Clinical trial landscape

By Christine Blazynski 25 Nov 2016

Due to popular demand, Christine has provided an encore of the landscape for 2015. In 2014 the analysis encompassed 4,301 Phase I through Phase III/IV completed and terminated trials; the top 3 diseases with completed trials were Type 2 diabetes, HCV and breast cancer.

Topics Clinical trial optimization

Pharmaprojects

The evolution of clinical research in East Asia

By Roger Longman 25 Nov 2016

Citeline Doro's analyzes the increased activity of clinical trials located in East Asia.  This report gives a detailed look into characteristics of trials currently being conducted and planned in East Asia.

Topics Infectious diseases

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:
Pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: